Gerhard Burits takes on new role at the ELATEC Group / RFID specialist ELATEC: New management duo with many years of experience
23.7.2024 09:00:00 CEST | news aktuell GmbH | Press release

Munich, July 23, 2024 – Gerhard Burits expands his responsibilities and assumes the role of CEO of the ELATEC Group. Thanks to his in-depth knowledge of the company structure and his strategic foresight, he is ideally qualified to reinforce ELATEC’s position as an innovation leader in global competition. The management board will have joint leaders at the helm: Also on board is Paul Massey, who, as CEO of ELATEC Inc., is now also taking on the role of COO of the ELATEC Group and contributing his international expertise to a greater extent.
Gerhard Burits, who joined the company in June 2020 as Chief Financial Officer (CFO), has been appointed Chief Executive Officer (CEO) of ELATEC GmbH. Over the past four years, he has made a significant contribution as CFO to financial stability and international growth, positioning ELATEC excellently with his strategic expertise. As CEO, he is now determined to reinforce the ELATEC Group’s technological lead, strengthen its presence on the global market, and thus initiate the next growth spurt. Personal thanks go to the previous CEO, Robert Helgerth, who is going into a well-deserved retirement after a successful career. Under his leadership, ELATEC has strengthened and solidified the basis for further growth.
Global expansion course with quality ‘Made in Germany’
The ELATEC Group will continue to remain true to its core areas of expertise under the new leadership: “Quality ‘Made in Germany’ remains of crucial importance to us while we adapt agilely to changing market requirements and continue to offer top service quality,” says CEO Gerhard Burits. As Chief Operating Officer (COO), Paul Massey will work closely with Gerhard Burits to drive forward the company’s global strategy and promote international expansion.
ELATEC’s mission: Technological leadership through innovation and employee strength
Gerhard Burits, CEO of the ELATEC Group, emphasizes: “Our mission is to further develop ELATEC as a technology leader. The key to that lies in the innovative strength of our core areas of expertise and in promoting our employees. A positive corporate culture with team spirit and flat hierarchies, characterized by ELATEC expertise, is important to us. That lays the foundation for us to adapt flexibly to changing market requirements and expand our technological lead.”
Paul Massey adds: “Our aim is to consolidate and expand our position as a leading provider of innovative and future-proof access systems. We will help our customers through our innovative solutions and world-class service to be successful in a rapidly changing environment.”
Available images for download:
https://elatec.me/3L6XuF1
- Picture is available at AP -
About ELATEC
ELATEC is a leading global provider of user authentication and identification solutions. Together with its global partners, the company develops innovative and future-proof access systems for its customers. With the interplay of pioneering multi-frequency readers, advanced authentication software and world-class service and support, ELATEC is driving the digital transformation of its customers and partners. The breakthrough solutions that result ensure an optimal user experience and are used in a wide range of applications and industries where secure and convenient access is required – including access control, fleet management, machine authentication, electric vehicle charging, secure printing, kiosks and more. Founded in 1988 and headquartered in Munich, Germany, the company is now represented at 19 locations worldwide.
For more information: www.elatec.com
Press contact ELATEC GmbH:
Anna Vanessa Evertz
Zeppelinstraße 1
82178 Puchheim
Germany
Tel.: +49895529961-180
E-mail: a.evertz@elatec.com
Press contact agency:
Maisberger GmbH
Claudius-Keller-Str. 3c
81669 Munich
Germany
E-mail: elatec@maisberger.com
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:52:44 CEST | Press release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Democracy News Alliance: Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:55:20 CEST | Press release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found.
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 13:06:01 CEST | Press release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 10:17:49 CEST | Press release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
